Schedule of Basic and Diluted Loss Per Share |
The following presents
the calculation of basic and diluted loss per share for the three and six months ended June 30, 2025 and 2024:
| |
For
the Three Months Ended June 30, | | |
For
the Six Months Ended June 30, | |
| |
2025 | | |
2024 | | |
2025 | | |
2024 | |
Basic and Diluted EPS | |
| | | |
| | | |
| | | |
| | |
Numerator | |
| | | |
| | | |
| | | |
| | |
Net loss attributable to the Company | |
$ | (28,274,027 | ) | |
$ | (11,575,542 | ) | |
$ | (15,188,220 | ) | |
$ | (24,005,787 | ) |
Preferred shares redemption value accretion | |
| — | | |
| (11,096,312 | ) | |
| (21,702,737 | ) | |
| (1,098,804,125 | ) |
Fair value of ordinary shares issued to preferred shareholders | |
| (513,080,828 | ) | |
| — | | |
| (513,080,828 | ) | |
| — | |
Fair value of ordinary share warrants issued to preferred
shareholders | |
| (15,600,000 | ) | |
| — | | |
| (15,600,000 | ) | |
| — | |
Excess carrying value of preferred shares repurchased | |
| 38,093,537 | | |
| — | | |
| 38,093,537 | | |
| — | |
Net loss attributable to ordinary shareholders | |
| (518,861,318 | ) | |
| (22,671,854 | ) | |
| (527,478,248 | ) | |
| (1,122,809,912 | ) |
Denominator | |
| | | |
| | | |
| | | |
| | |
Weighted-average shares outstanding – basic
and diluted | |
| 431,390,035 | | |
| 138,878,054 | | |
| 286,155,488 | | |
| 138,346,243 | |
Basic and diluted loss per share | |
$ | (1.20 | ) | |
$ | (0.16 | ) | |
$ | (1.84 | ) | |
$ | (8.12 | ) |
|
The following presents
the calculation of basic and diluted loss per share for the years ended December 31, 2024, 2023 and 2022:
| |
2024 | | |
2023 | | |
2022 | |
(Loss) income from continuing operations
attributable to the Company | |
$ | (25,385,426 | ) | |
$ | 4,284,819 | | |
$ | 33,473,969 | |
Preferred shares redemption value accretion | |
| (495,088,038 | ) | |
| (340,080,000 | ) | |
| (51,409,749 | ) |
Loss from continuing operations
attributable to ordinary shareholders | |
$ | (520,473,464 | ) | |
$ | (335,795,181 | ) | |
$ | (17,935,780 | ) |
| |
| | | |
| | | |
| | |
Weighted-average shares outstanding
- basic and diluted | |
| 138,828,900 | | |
| 137,965,591 | | |
| 134,489,965 | |
Basic and diluted earnings per share | |
$ | (3.75 | ) | |
$ | (2.43 | ) | |
$ | (0.13 | ) |
|
Schedule of Diluted Net Loss per Ordinary Share Effect Anti-Dilutive |
The following table summarizes
potential ordinary shares outstanding that were excluded from the calculation of diluted net loss per ordinary share, because their effect
would have been anti-dilutive:
| |
For the Three Months Ended
June 30, | | |
For the Six Months Ended
June 30, | |
| |
2025 | | |
2024 | | |
2025 | | |
2024 | |
Options | |
| 33,057,765 | | |
| 33,534,491 | | |
| 33,057,765 | | |
| 33,534,491 | |
RSAs | |
| 8,079,896 | | |
| 5,678,013 | | |
| 8,079,896 | | |
| 5,678,013 | |
RSUs | |
| 8,046,477 | | |
| 7,678,486 | | |
| 8,046,477 | | |
| 7,678,486 | |
Public warrants | |
| 9,675,386 | | |
| — | | |
| 9,675,386 | | |
| — | |
Convertible redeemable preferred shares: | |
| | | |
| | | |
| | | |
| | |
Series A-1 | |
| — | | |
| 50,997,533 | | |
| — | | |
| 50,997,533 | |
Series A-2 | |
| — | | |
| 47,849,869 | | |
| — | | |
| 47,849,869 | |
Series A-3 | |
| — | | |
| 9,503,120 | | |
| — | | |
| 9,503,120 | |
Series B-1 | |
| — | | |
| 44,047,138 | | |
| — | | |
| 44,047,138 | |
Series B-2 | |
| — | | |
| 30,539,060 | | |
| — | | |
| 30,539,060 | |
Series B-3 | |
| — | | |
| 7,054,530 | | |
| — | | |
| 7,054,530 | |
Series C | |
| — | | |
| 45,971,349 | | |
| — | | |
| 45,971,349 | |
Series D | |
| — | | |
| 43,548,544 | | |
| — | | |
| 43,548,544 | |
Total convertible redeemable preferred
shares | |
| — | | |
| 279,511,143 | | |
| — | | |
| 279,511,143 | |
Total potential ordinary shares outstanding | |
| 58,859,524 | | |
| 326,402,133 | | |
| 58,859,524 | | |
| 326,402,133 | |
|
The following table summarizes
potential ordinary shares outstanding that were excluded from the calculation of diluted net loss per ordinary share because their effect
would have been anti-dilutive:
| |
2024 | | |
2023 | | |
2022 | |
Options | |
| 32,490,743 | | |
| 30,717,331 | | |
| 28,716,868 | |
RSAs | |
| 1,295,450 | | |
| 2,590,897 | | |
| 5,181,794 | |
RSUs | |
| 7,694,426 | | |
| 5,006,247 | | |
| 3,448,445 | |
Convertible redeemable preferred shares: | |
| | | |
| | | |
| | |
Series A-1 | |
| 50,997,533 | | |
| 50,997,533 | | |
| 50,997,533 | |
Series A-2 | |
| 47,849,869 | | |
| 47,849,869 | | |
| 47,849,869 | |
Series A-3 | |
| 9,503,120 | | |
| 9,503,120 | | |
| 9,503,120 | |
Series B-1 | |
| 44,047,138 | | |
| 44,047,138 | | |
| 44,047,138 | |
Series B-2 | |
| 30,539,060 | | |
| 30,539,060 | | |
| 30,539,060 | |
Series B-3 | |
| 7,054,530 | | |
| 7,054,530 | | |
| 7,054,530 | |
Series C | |
| 45,971,348 | | |
| 45,971,348 | | |
| 45,971,348 | |
Series D | |
| 43,548,544 | | |
| 39,464,250 | | |
| 37,437,167 | |
Total convertible
redeemable preferred shares | |
| 279,511,142 | | |
| 275,426,850 | | |
| 273,399,768 | |
Total potential ordinary shares
outstanding | |
| 320,991,761 | | |
| 313,741,326 | | |
| 310,746,876 | |
|